Living Our Values

Our Environmental, Social, and Governance commitments help us to deliver on our purpose every day. Learn more about our progress on our goals in our ESG report.

Grid of multiple images that comprise the CEO...

2022 ESG Highlights


The health of our global environment impacts everyone. At Pfizer, we are committed to reducing our environmental footprint. Our company purpose—Breakthroughs that change patients’ lives—guides our environmental priorities, with a focus on impact reduction, conservation of resources, and the minimization of waste arising from our operations.

Leaf illustration

Net-Zero Standard

Aiming to achieve by 2040, which is 10 years earlier than expectations of the standard
Star illustration
Recognized at the

Leadership Level

for our CDP Climate Change Disclosure
Waterdrop with jagged downward pointing arrow illustration


Reduction in Scope 1 & 2 greenhouse gas (GHG) emissions from 2019 baseline
Aerial view of a forest


At Pfizer, our purpose—Breakthroughs that change patients’ lives—is rooted in achieving social good. We know that when we succeed, our breakthroughs can potentially have life-changing effects. We aim to be the solution for illnesses from widespread infectious diseases to conditions with historically unmet need.

Pfizer is mindful of the urgency of our mission, as the world fights against the spread of deadly new diseases and struggles with inequities in health outcomes among populations. Our goal is to leverage partnerships and programs to allow quick and widespread access to our breakthrough medicines and vaccines across all corners of the world.

Blue heart next to a doctor with a stethoscope over shoulder illustration


Ranking among the largest Pharma companies in the most recent Global PatientView Survey (#2 overall)
Group of people illustration


Representation for women at VP+ levels globally. 28.1% Representation for U.S. minorities at VP+ level
Glowing molecule illustration


Pfizer New Molecular Entity and novel biologic applications approved by the FDA between 2018-2022 designated as Breakthrough Therapies
A woman wearing glasses


Ethical decision-making guides us as we work to achieve our purpose of delivering Breakthroughs that change patients’ lives. Through proactive, business-led risk management, Pfizer prioritizes integrity, safety, and quality in every aspect of our business. Our Board of Directors is actively engaged in the governance and oversight of our ESG strategy, which is embedded within our enterprise strategy.

Round table with some chairs highlighted in shades of blue illustration

4 out of 12

Members of the board of directors are women
3 out of 12 members of the Board of Directors are ethnically diverse
World's most ethical companies award logo
Named one of the World’s Most Ethical Companies by Ethisphere for the second year in a row
Outline of people and chart illustration


Pfizer leaders have ESG KPIs factored into their compensation
Aerial view of a round conference table
A Closer Look at ESG

Portrait of Alebrt Bourla, Pfizer Chairman & Chief Executive Officer
“Our approach to helping address the issues facing our planet and its people is rooted in our purpose - Breakthroughs that change patients’ lives.
Dr. Albert Bourla
Pfizer Chairman & Chief Executive Officer